Parp2 Rat (-)-demecolcine decreases expression ISO RGD:1602134 6480464 Demecolcine results in decreased expression of PARP2 mRNA CTD PMID:23649840 Parp2 Rat 1,2-dichloroethane increases expression ISO RGD:1553525 6480464 ethylene dichloride results in increased expression of PARP2 mRNA CTD PMID:28960355 Parp2 Rat 1,2-dimethylhydrazine increases expression ISO RGD:1553525 6480464 1,2-Dimethylhydrazine results in increased expression of PARP2 mRNA CTD PMID:22206623 Parp2 Rat 1,3-dinitrobenzene decreases expression EXP 6480464 3-dinitrobenzene results in decreased expression of PARP2 mRNA CTD PMID:21983209 Parp2 Rat 17alpha-ethynylestradiol increases expression ISO RGD:1553525 6480464 Ethinyl Estradiol results in increased expression of PARP2 mRNA CTD PMID:17942748 Parp2 Rat 17alpha-ethynylestradiol multiple interactions ISO RGD:1553525 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PARP2 mRNA CTD PMID:17942748 Parp2 Rat 17beta-estradiol increases expression ISO RGD:1553525 6480464 Estradiol results in increased expression of PARP2 mRNA CTD PMID:39298647 Parp2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1553525 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PARP2 mRNA CTD PMID:17942748 Parp2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1602134 6480464 Tetrachlorodibenzodioxin affects the expression of PARP2 mRNA CTD PMID:22574217 Parp2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1553525 6480464 Tetrachlorodibenzodioxin affects the expression of PARP2 mRNA CTD PMID:21570461 Parp2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1553525 6480464 Tetrachlorodibenzodioxin results in increased expression of PARP2 mRNA CTD PMID:17942748 Parp2 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2,4-dinitrotoluene affects the expression of PARP2 mRNA CTD PMID:21346803 Parp2 Rat 2-methylcholine affects expression ISO RGD:1602134 6480464 beta-methylcholine affects the expression of PARP2 mRNA CTD PMID:21179406 Parp2 Rat 3-aminobenzamide affects binding ISO RGD:1602134 6480464 PARP2 protein binds to 3-aminobenzamide CTD PMID:20092359 Parp2 Rat 4,4'-sulfonyldiphenol increases expression ISO RGD:1553525 6480464 bisphenol S results in increased expression of PARP2 mRNA CTD PMID:39298647 Parp2 Rat antimycin A increases expression ISO RGD:1602134 6480464 Antimycin A results in increased expression of PARP2 mRNA CTD PMID:33512557 Parp2 Rat antirheumatic drug increases expression ISO RGD:1602134 6480464 Antirheumatic Agents results in increased expression of PARP2 mRNA CTD PMID:24449571 Parp2 Rat arsane multiple interactions ISO RGD:1602134 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Parp2 Rat arsenic atom multiple interactions ISO RGD:1602134 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Parp2 Rat arsenous acid increases expression ISO RGD:1602134 6480464 Arsenic Trioxide results in increased expression of PARP2 mRNA CTD PMID:20458559 Parp2 Rat benzo[a]pyrene increases expression ISO RGD:1553525 6480464 Benzo(a)pyrene results in increased expression of PARP2 mRNA CTD PMID:22228805 Parp2 Rat benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1602134 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PARP2 mRNA CTD PMID:20382639 Parp2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PARP2 mRNA CTD PMID:25181051 Parp2 Rat bisphenol A increases methylation ISO RGD:1602134 6480464 bisphenol A results in increased methylation of PARP2 gene CTD PMID:31601247 Parp2 Rat bisphenol A multiple interactions ISO RGD:1602134 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PARP2 gene CTD PMID:31601247 Parp2 Rat bisphenol A increases expression ISO RGD:1602134 6480464 bisphenol A results in increased expression of PARP2 mRNA CTD PMID:33670352 Parp2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PARP2 mRNA CTD PMID:30816183|PMID:32528016|PMID:34947998 Parp2 Rat bisphenol A decreases expression ISO RGD:1602134 6480464 bisphenol A results in decreased expression of PARP2 mRNA CTD PMID:29275510 Parp2 Rat bisphenol F decreases expression ISO RGD:1553525 6480464 bisphenol F results in decreased expression of PARP2 mRNA CTD PMID:38685157 Parp2 Rat cadmium dichloride decreases expression ISO RGD:1602134 6480464 Cadmium Chloride results in decreased expression of PARP2 mRNA CTD PMID:38568856 Parp2 Rat calcitriol decreases expression ISO RGD:1602134 6480464 Calcitriol results in decreased expression of PARP2 mRNA CTD PMID:21592394 Parp2 Rat calcitriol multiple interactions ISO RGD:1602134 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of PARP2 mRNA CTD PMID:21592394 Parp2 Rat cisplatin increases expression ISO RGD:1602134 6480464 Cisplatin results in increased expression of PARP2 mRNA; Cisplatin results in increased expression of PARP2 more ... CTD PMID:21274007|PMID:27594783 Parp2 Rat clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of PARP2 mRNA CTD PMID:12851107 Parp2 Rat copper atom multiple interactions ISO RGD:1602134 6480464 [Chelating Agents binds to Copper] which results in increased expression of PARP2 mRNA CTD PMID:30911355 Parp2 Rat copper(0) multiple interactions ISO RGD:1602134 6480464 [Chelating Agents binds to Copper] which results in increased expression of PARP2 mRNA CTD PMID:30911355 Parp2 Rat coumestrol increases expression ISO RGD:1602134 6480464 Coumestrol results in increased expression of PARP2 mRNA CTD PMID:19167446 Parp2 Rat coumestrol multiple interactions ISO RGD:1602134 6480464 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP2 mRNA; [Coumestrol co-treated with resveratrol] more ... CTD PMID:19167446 Parp2 Rat cyclosporin A increases expression ISO RGD:1602134 6480464 Cyclosporine results in increased expression of PARP2 mRNA CTD PMID:25562108 Parp2 Rat cypermethrin increases expression ISO RGD:1602134 6480464 cypermethrin results in increased expression of PARP2 mRNA CTD PMID:27704156 Parp2 Rat DDE increases expression ISO RGD:1602134 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of PARP2 mRNA CTD PMID:38568856 Parp2 Rat deguelin increases expression ISO RGD:1602134 6480464 deguelin results in increased expression of PARP2 mRNA CTD PMID:33512557 Parp2 Rat diarsenic trioxide increases expression ISO RGD:1602134 6480464 Arsenic Trioxide results in increased expression of PARP2 mRNA CTD PMID:20458559 Parp2 Rat dioxygen multiple interactions ISO RGD:1553525 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of PARP2 mRNA CTD PMID:30529165 Parp2 Rat Enterolactone multiple interactions ISO RGD:1602134 6480464 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP2 mRNA CTD PMID:19167446 Parp2 Rat fenpyroximate increases expression ISO RGD:1602134 6480464 fenpyroximate results in increased expression of PARP2 mRNA CTD PMID:33512557 Parp2 Rat FR900359 decreases phosphorylation ISO RGD:1602134 6480464 FR900359 results in decreased phosphorylation of PARP2 protein CTD PMID:37730182 Parp2 Rat fulvestrant multiple interactions ISO RGD:1602134 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PARP2 gene CTD PMID:31601247 Parp2 Rat furan decreases expression EXP 6480464 furan results in decreased expression of PARP2 mRNA CTD PMID:22507866 Parp2 Rat gemcitabine decreases response to substance ISO RGD:1602134 6480464 PARP2 protein results in decreased susceptibility to Gemcitabine CTD PMID:20798217 Parp2 Rat glyphosate increases expression ISO RGD:1602134 6480464 Glyphosate results in increased expression of PARP2 mRNA CTD PMID:31874349 Parp2 Rat lead(0) decreases expression ISO RGD:1602134 6480464 Lead results in decreased expression of PARP2 mRNA CTD PMID:19921347 Parp2 Rat leflunomide decreases expression ISO RGD:1602134 6480464 leflunomide results in decreased expression of PARP2 mRNA CTD PMID:28988120 Parp2 Rat manganese atom multiple interactions ISO RGD:1602134 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Parp2 Rat manganese(0) multiple interactions ISO RGD:1602134 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Parp2 Rat manganese(II) chloride multiple interactions ISO RGD:1602134 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Parp2 Rat methotrexate increases expression ISO RGD:1602134 6480464 Methotrexate results in increased expression of PARP2 mRNA CTD PMID:24449571 Parp2 Rat methyl methanesulfonate increases expression ISO RGD:1602134 6480464 Methyl Methanesulfonate results in increased expression of PARP2 mRNA CTD PMID:23649840 Parp2 Rat N-methyl-N-nitrosourea increases response to substance ISO RGD:1553525 6480464 PARP2 gene mutant form results in increased susceptibility to Methylnitrosourea CTD PMID:12727891 Parp2 Rat niraparib multiple interactions ISO RGD:1602134 6480464 niraparib binds to and results in decreased activity of PARP2 protein CTD PMID:28001384 Parp2 Rat nitrates multiple interactions ISO RGD:1553525 6480464 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PARP2 more ... CTD PMID:35964746 Parp2 Rat olaparib multiple interactions ISO RGD:1602134 6480464 olaparib binds to and results in decreased activity of PARP2 protein CTD PMID:28001384 Parp2 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PARP2 mRNA CTD PMID:25729387 Parp2 Rat paracetamol increases expression ISO RGD:1602134 6480464 Acetaminophen results in increased expression of PARP2 mRNA CTD PMID:22230336 Parp2 Rat paracetamol increases expression ISO RGD:1553525 6480464 Acetaminophen results in increased expression of PARP2 mRNA CTD PMID:34219507 Parp2 Rat phorbol 13-acetate 12-myristate increases expression ISO RGD:1602134 6480464 Tetradecanoylphorbol Acetate results in increased expression of PARP2 mRNA CTD PMID:19031421 Parp2 Rat resveratrol multiple interactions ISO RGD:1602134 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of PARP2 mRNA CTD PMID:19167446 Parp2 Rat resveratrol decreases expression EXP 6480464 Resveratrol results in decreased expression of PARP2 mRNA CTD PMID:33775663 Parp2 Rat rucaparib decreases activity ISO RGD:1602134 6480464 rucaparib results in decreased activity of PARP2 protein CTD PMID:28001384 Parp2 Rat sodium arsenite increases expression ISO RGD:1602134 6480464 sodium arsenite results in increased expression of PARP2 mRNA CTD PMID:38568856 Parp2 Rat sodium arsenite multiple interactions ISO RGD:1602134 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Parp2 Rat Soman decreases expression EXP 6480464 Soman results in decreased expression of PARP2 mRNA CTD PMID:19281266 Parp2 Rat sulforaphane multiple interactions ISO RGD:1553525 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of PARP2 mRNA CTD PMID:30529165 Parp2 Rat talazoparib decreases activity ISO RGD:1602134 6480464 talazoparib results in decreased activity of PARP2 protein CTD PMID:28001384 Parp2 Rat tanespimycin increases expression ISO RGD:1602134 6480464 tanespimycin analog results in increased expression of PARP2 protein CTD PMID:31370342 Parp2 Rat tebufenpyrad increases expression ISO RGD:1602134 6480464 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of PARP2 mRNA CTD PMID:33512557 Parp2 Rat testosterone multiple interactions ISO RGD:1602134 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of PARP2 mRNA CTD PMID:21592394 Parp2 Rat testosterone decreases expression ISO RGD:1602134 6480464 Testosterone results in decreased expression of PARP2 mRNA CTD PMID:21592394 Parp2 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PARP2 mRNA CTD PMID:25729387 Parp2 Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of PARP2 mRNA CTD PMID:25729387 Parp2 Rat triphenyl phosphate affects expression ISO RGD:1602134 6480464 triphenyl phosphate affects the expression of PARP2 mRNA CTD PMID:37042841 Parp2 Rat valproic acid decreases methylation ISO RGD:1602134 6480464 Valproic Acid results in decreased methylation of PARP2 gene CTD PMID:29154799 Parp2 Rat valproic acid decreases expression ISO RGD:1602134 6480464 Valproic Acid results in decreased expression of PARP2 mRNA CTD PMID:23179753 Parp2 Rat valproic acid affects expression ISO RGD:1602134 6480464 Valproic Acid affects the expression of PARP2 mRNA CTD PMID:25979313 Parp2 Rat veliparib affects binding ISO RGD:1602134 6480464 PARP2 protein binds to veliparib CTD PMID:20092359 Parp2 Rat veliparib multiple interactions ISO RGD:1602134 6480464 veliparib binds to and results in decreased activity of PARP2 protein CTD PMID:28001384 Parp2 Rat veliparib decreases activity ISO RGD:1602134 6480464 veliparib results in decreased activity of PARP2 protein CTD PMID:19143569|PMID:21917757 Parp2 Rat vincristine decreases expression ISO RGD:1602134 6480464 Vincristine results in decreased expression of PARP2 mRNA CTD PMID:23649840 Parp2 Rat XAV939 decreases activity ISO RGD:1602134 6480464 XAV939 results in decreased activity of PARP2 protein CTD PMID:28001384